Nimsi SP 100mg/325mg/10mg Tablet
By Nimsi SP
Rx
10 Tablet in a Strip

Composition
Nimesulide(100mg) + Paracetamol(325mg) + Serratiopeptidase(10mg)

Manufacturer - Symbiosis Pharmaceuticals Pvt Ltd
Symbiosis Pharma Pvt. Ltd., Suketi Road, Kala Amb - 173030 (HP)

Expires on or after
September, 2025

liver
There is limited information on how Nimsi SP 100mg/325mg/10mg Tablet affects patients with liver disease. It is advised to consult your doctor before using this medication if you have any liver issues. Your doctor can provide proper guidance based on your specific situation.

kidney
Nimsi SP 100mg/325mg/10mg Tablet requires caution in patients with kidney disease. Dosage adjustment may be necessary. Avoid use in severe kidney disease. Consult your doctor before using Nimsi SP 100mg/325mg/10mg Tablet.

alcohol
It is not safe to drink alcohol while taking Nimsi SP 100mg/325mg/10mg Tablet.

driving
It is uncertain if Nimsi SP 100mg/325mg/10mg Tablet impacts driving ability. Avoid driving if you have symptoms that affect concentration and reaction time.

pregnancy
It is advisable to consult your doctor before using Nimsi SP 100mg/325mg/10mg Tablet during pregnancy as there is no specific information available regarding its safety in pregnancy.

breastfeeding
It is better to consult your doctor before using Nimsi SP 100mg/325mg/10mg Tablet during breastfeeding.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | PAIN ANALGESICS |
Action Class | - |
₹29.4
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024